Filing Details
- Accession Number:
- 0001159036-14-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-16 16:26:04
- Reporting Period:
- 2014-05-15
- Filing Date:
- 2014-05-16
- Accepted Time:
- 2014-05-16 16:26:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1078452 | Robert Engler | C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-15 | 150,000 | $4.10 | 359,876 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-05-15 | 126,700 | $7.56 | 233,176 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock (NSO) | Disposition | 2014-05-15 | 150,000 | $4.10 | 150,000 | $4.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2005-05-21 | 2014-05-21 | No | 4 | M | Direct |
Billionaire Hedge Funds
